HEAD AND NECK MANIFESTATIONS OF METASTATIC BREAST-CANCER - A REVIEW

被引：0

作者：

DEBOIS, JM ^{[1
]}

机构：

[1] EUWFEESTKLIN,DEPT RADIOTHERAPY & ONCOL,B-2018 ANTWERP,BELGIUM

来源：

TUMORDIAGNOSTIK & THERAPIE | 1995年 / 16卷 / 04期

关键词：

BREAST CANCER; HEAD AND NECK METASTASES; DIAGNOSIS;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Distant metastases from breast cancer can occur in many anatomical locations. Those in the head and neck region have interesting clinical aspects in view of their symptoms and problems in their diagnosis. Review is made of the different diagnostic problems, their incidence and treatment, which can be very rewarding in many situations.

引用

页码：139 / 147

页数：9

共 50 条

[41] POTENTIAL FOR COST ECONOMIES IN GUIDING THERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER [J].

ROBERTSON, JFR ;

WHYNES, DK ;

DIXON, A ;

BLAMEY, RW .

BRITISH JOURNAL OF CANCER, 1995, 72 (01) :174-177

[42] Coexpress of GATA-3 and ER in Anorectal and Head and Neck Squamous Cell Carcinoma Mimicking Metastatic Breast Cancer [J].

Wang, Yihong ;

Lu, Shaolei ;

Amin, Ali ;

Wang, Lijuan .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (06) :409-413

[43] PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER [J].

MILLWARD, MJ ;

NEWELL, DR ;

YUEN, K ;

MATTHEWS, JP ;

BALMANNO, K ;

CHARLTON, CJ ;

GUMBRELL, L ;

LIND, MJ ;

CHAPMAN, F ;

PROCTOR, M ;

SIMMONDS, D ;

CANTWELL, BMJ ;

CALVERT, AH .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 37 (1-2) :161-167

[44] TESTOSTERONE LEVELS AS A MARKER OF PROGNOSIS TO GOSERELIN TREATMENT IN METASTATIC BREAST-CANCER [J].

SECRETO, G ;

BORACCHI, P ;

BUZZONI, R ;

VENTURELLI, E ;

CAVALLERI, A ;

DOLCI, S .

EUROPEAN JOURNAL OF CANCER, 1994, 30A (11) :1629-1631

[45] RHYTHM ALTERATION IN PATIENTS WITH METASTATIC BREAST-CANCER AND POOR PROGNOSTIC FACTORS [J].

TOUITOU, Y ;

LEVI, F ;

BOGDAN, A ;

BENAVIDES, M ;

BAILLEUL, F ;

MISSET, JL .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1995, 121 (03) :181-188

[46] PHASE-II TRIAL OF DOXORUBICIN AND TRIFLUOPERAZINE IN METASTATIC BREAST-CANCER [J].

BUDD, GT ;

BUKOWSKI, RM ;

LICHTIN, A ;

BAUER, L ;

VANKIRK, P ;

GANAPATHI, R .

INVESTIGATIONAL NEW DRUGS, 1993, 11 (01) :75-79

[47] ANALYSIS OF TIME TO RESPONSE TO CHEMOTHERAPY IN 316 METASTATIC BREAST-CANCER PATIENTS [J].

PRONZATO, P ;

BERTELLI, G ;

GARDIN, G ;

RUBAGOTTI, A ;

CONTE, PF ;

ROSSO, R .

ONCOLOGY, 1993, 50 (06) :460-465

[48] TYPE-B LACTIC-ACIDOSIS AND METASTATIC BREAST-CANCER [J].

WARNER, E .

BREAST CANCER RESEARCH AND TREATMENT, 1992, 24 (01) :75-79

[49] IS STEROID-RECEPTOR DATA USEFUL IN PATIENTS WITH METASTATIC BREAST-CANCER [J].

WARDE, P ;

DETSKY, AS .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1992, 304 (01) :9-13

[50] INTENSIVE CHEMOTHERAPY WITH CISPLATIN, MITOXANTRONE, METHOTREXATE AND VINCRISTINE IN METASTATIC BREAST-CANCER [J].

QUEIROLO, P ;

REPETTO, L ;

GARDIN, G ;

MIGLIETTA, L ;

GUIDO, T ;

PRONZATO, P ;

ROSSO, R .

JOURNAL OF CHEMOTHERAPY, 1991, 3 (03) :194-197

← 1 2 3 4 5 →